Menu

Recent Interviews

Jerre Foo, Corporate Development Executive, Silkroad Nickel

Jerre Foo
Corporate Development Executive | Silkroad Nickel
50 Armenian Street #03-04, 179938 Singapore (SGP)

enquiries@silkroadnickel.com

+65 6327 8971

Silkroad Nickel: 'The course is set for dynamic profit growth.'


Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG

Dr. Thomas Gutschlag
CEO | Deutsche Rohstoff AG
Q7, 24, 68161 Mannheim (D)

info@rohstoff.de

+49 621 490 817 0

Interview Deutsche Rohstoff AG: "We can imagine additional investments in the field of electromobility."


Steve Cope, President, CEO and Director, Silver Viper

Steve Cope
President, CEO and Director | Silver Viper
1055 W Hastings St Suite 1130, V6E 2E9 Vancouver (CAN)

info@silverviperminerals.com

+1-604-687-8566

Interview with Silver Viper: Future price drivers and takeover fantasy


30. September 2020 | 11:45 CET

BAT, Barrick Gold, Osino Resources: Supposed political risks, a burden, and an opportunity

  • Investments
Photo credits: pixabay.com

Businesses, like citizens, operate within the regulatory framework. In this way, the state guarantees peaceful coexistence. But what if the legal framework changes? It is easy for individuals to adapt to new circumstances. It can be more challenging for companies - for example, if a business model is shaken by regulatory requirements. The best example is the tobacco company BAT. Recently, the German Bundesrat cleared the way for a law that further restricts advertising for tobacco products. Even e-cigarettes, celebrated by the industry as a source of hope, will be subject to the likely ban. Cinema advertising, marketing activities, etc will also be restricted in the future.

time to read: 3 minutes by Nico Popp


 

Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author


BAT: Good figures fizzle out on the market

For companies like BAT, the new laws in Germany are just another chapter in the never-ending story. But although smokers and tobacco companies have been facing headwinds for years, BAT is holding up comparatively well. In the first half of the year, the group even managed to increase its profits by more than 20%.

The driving force continues to be e-cigarettes, which - despite political headwinds - are popular with customers. BAT is also favorably valued: the price-earnings ratio is below 10, and the dividend yield is also impressive at around 8%. Nevertheless, the share is not a high-flyer on the stock market: on a one-year horizon, despite the solid-key data, a loss of around 3% is recorded. Investors seem to find the anti-smoking policy so deterrent that they are avoiding the share despite the positive figures.

Barrick Gold has costs under control

The Barrick Gold share shows that political headwinds do not always have to result in falling prices. The company is still in dispute with Papua New Guinea over the resumption of production at the Porger Mine. The background is environmental damage, which the country would like to see Barrick repair. For its part, the company announces that it intends to resolve the dispute and take all necessary steps. Nevertheless, the dispute continues to smolder. In recent years, Barrick has also been involved in conflicts with authorities in other regions of the world, such as Chile, but that has not hurt the share. On a one-year horizon, Barrick climbed by almost 50%.

Investors appreciate the share's robust sales growth and low costs. In times when gold prices are rising, this provides a comfortable cushion. In recent months there have been sales of mines that the Group considers unprofitable. Barrick primarily mines gold but also has copper on offer. Both commodities have been performing well since the pandemic, so it can be assumed that the disease will not play any role in Barrick's figures.

Osino Resources seeks gold in Namibia

The Osino Resources share has also benefited from the development of the past six months - since the end of March, the share price has only known one direction, and that is up. It has increased by 61% on a one-year horizon. Osino Resources is a Canadian commodities company specializing in gold exploration in Namibia. Namibia is considered one of the most stable countries in Africa with highly developed mining standards and an industry minded government. Osino Resources operates in the promising gold belt northeast of the capital Windhoek. Within twenty kilometres around the company's properties are roads, access to energy, and other essential infrastructure. By the end of 2020, the company plans to confirm and expand on promising results already achieved by drilling new wells.

Insiders and professional investors rely on Osino Resources

The experienced management team believes in itself and the project, this is shown by the high proportion of Osino shares in its portfolio: around 38% are in the hands of insiders or other persons associated with the company. Professional investors hold another 34%. Private investors, therefore, account for only ~28% of the company's shareholders. Many private investors still shy away from investing in Africa and see political risks.

Osino Resources does not see such fears and emphasises the advantages of Namibia as a mining location. The country has a mining history of more than 110 years. Raw materials contribute to a large extent to the country's gross domestic product. As Namibia has been a democracy since 1990, workers and residents of mining projects have rights and can enforce them. The risk of unrest, strikes, and other complications is lower in Namibia than in many other traditional mining regions.


Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

20. April 2021 | 09:45 CET | by Stefan Feulner

Varta, Sierra Growth, CureVac - Clear signals!

  • Investments

Sometimes, for various reasons, it takes longer before the positive developments of a Company are absorbed by the market and thus provide for price gains. It is currently similar to the precious metal gold, which is still in the consolidation phase. The facts such as national debt, inflation fears and the ultra-loose monetary policy of the central banks speak another clear language.

Read

20. April 2021 | 07:10 CET | by Carsten Mainitz

BioNTech, SunMirror, Steinhoff - Great News!

  • Investments

Shortly before the finish line, the going gets tough again. Many athletes and those who have to really "bite" in the last few meters before a deadline are probably familiar with this feeling. Everyday life in the Corona pandemic is also becoming more exhausting. Now, with BioNTech's announcement that it will double weekly vaccine dose deliveries to around 5.1 million units from the end of May, there may be a breakthrough in achieving herd immunity in Germany in the next few months. It is not only good news for the Company's shareholders but everyone. Below we present two other companies whose shareholders should be very pleased. Let us surprise you!

Read

15. April 2021 | 07:15 CET | by Stefan Feulner

Alibaba, The Place Holdings, CureVac - Great opportunities lie here!

  • Investments

The German vaccination disaster is going into the next round. After the AstraZeneca vaccine's back and forth and the question of whether only younger people, older people or no one should be vaccinated with the vaccine, the American vaccine manufacturer Johnson & Johnson is now experiencing delivery stoppages. The return to "normality" once again seems to be a long way off. Another question to ask yourself. What will future life in the new normal look like in the hard-pressed inner cities?

Read